30.04.2025 • News

Petronas Inaugurates Specialty Chemicals Laboratory in Shanghai

Perstorp and BRB, wholly-owned subsidiaries of Petronas Chemicals Group (PCG), inaugurated an innovation hub in Shanghai, China. The laboratory opened on April 17th and will support growth in the region by increasing technical support for customers with a specific focus on the Asian market. The new Shanghai innovation hub will have a strong focus on product and application development. It is one of several planned initiatives in the region to enhance innovation capabilities along the value chain.

Inauguration of new specialty chemicals laboratory in Shanghai.
Inauguration of new specialty chemicals laboratory in Shanghai.
© Perstorp

The innovation hub will serve various market segments, such as Synthetic Lubricants, Thermal Management Fluids, Personal Care and Coating Solutions, as well as the existing Silicones and intermediates business.

“This investment reinforces our commitment to innovation and co-creation with our customers, as well as strengthening our global presence. It reflects our growth agenda, our strong ambition and commitment to progress,” commented Debbie Chiu, COO of PCG Specialty Chemicals.

“With faster response times and reduced time to market, we are equipped to anticipate industry trends and deliver tailored solutions that meet our customers’ needs. This platform will enable more face-to-face interactions with customers in the Greater China and Asian market, to develop innovative solutions that align with market demands,” added Axel Tuchlenski, Head of Innovation at PCG Specialty Chemicals.

This is the latest of several application and development centers where PCG collaborates with customers to innovate new solutions. The inauguration on April 17, 2025, brought together customers from the different segments that the new lab will serve in the future.

Company

Petronas

Level 65, Tower 2, PETRONAS Twin Towers
50088 Kuala Lumpur
Malaysia

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.